293b cpd has been researched along with Cystic Fibrosis of Pancreas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandis, M; Gonska, T; Kuehr, J; Kunzelmann, K; Mall, M; Schreiber, R; Seydewitz, HH; Thomas, J | 1 |
| Cuthbert, AW; Hickman, ME; MacVinish, LJ; Thorn, P | 1 |
| Brandis, M; Greger, R; Kuehr, J; Kunzelmann, K; Mall, M; Schreiber, R; Seydewitz, HH; Wissner, A | 1 |
3 other study(ies) available for 293b cpd and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Modulation of Ca2+-activated Cl- secretion by basolateral K+ channels in human normal and cystic fibrosis airway epithelia.
Topics: Adolescent; Adult; Aged; Biological Transport; Calcium; Child; Child, Preschool; Chloride Channels; Chlorides; Chromans; Clotrimazole; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Gene Expression; Growth Inhibitors; Humans; Intermediate-Conductance Calcium-Activated Potassium Channels; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Male; Middle Aged; Nasal Mucosa; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Potassium Channels, Voltage-Gated; Sulfonamides; Uridine Triphosphate | 2003 |
Activation of Ca(2+)- and cAMP-sensitive K(+) channels in murine colonic epithelia by 1-ethyl-2-benzimidazolone.
Topics: Animals; Benzimidazoles; Calcium; Calcium Channel Agonists; Charybdotoxin; Chlorides; Chromans; Colon; Cyclic AMP; Cystic Fibrosis; Drug Synergism; Electric Conductivity; Intestinal Mucosa; Mice; Potassium Channel Blockers; Potassium Channels; Sulfonamides | 1999 |
Role of K(V)LQT1 in cyclic adenosine monophosphate-mediated Cl(-) secretion in human airway epithelia.
Topics: 1-Methyl-3-isobutylxanthine; Amiloride; Biological Transport; Bronchi; Cell Line, Transformed; Chlorides; Chromans; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diuretics; Gene Expression; Humans; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Membrane Potentials; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Respiratory Mucosa; Sulfonamides | 2000 |